Delivery Order SPE2DB25D7068-SPE2DB25FTYAL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablet, unit dose, 30-count packages, with a ceiling value of $1,006.45. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 25, 2025. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $3,157.92 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,002.44 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30 count). This is a firm fixed price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 28, 2025. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $6,021.48 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count). This competitively awarded, firm fixed-price delivery order was issued on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract requires performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,833.03 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $6,839.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30-count). This non-competitive delivery order, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30 count) valued at $4,513.88. This competitively awarded, firm fixed-price delivery order was issued on September 12, 2025, with an ultimate completion date of September 15, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 9, 2025, valued at $1,227.09 for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packages of 30. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of September 10, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) with a ceiling value of $1,441.33. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, executing under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX. The prime contract, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30 count) valued at $7,988.25. This is a firm fixed price delivery order with an ultimate completion date of June 3, 2025, and represents a non-competitive award. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTYALDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30 count), valued at $15,288.87. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. This order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The SPE2DX contract enables the company to supply a broad range of pharmaceutical products and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This particular delivery order for an antihypertensive medication reflects the company's role as a critical vendor in the military medical supply chain, fulfilling routine pharmaceutical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.3k | 9/18/25 |